Insider Transactions in Q2 2022 at Elevance Health, Inc. (ELV)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2022
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
SELL
Open market or private sale
|
Direct |
6,328
-6.86%
|
$3,094,392
$489.56 P/Share
|
|
Jun 09
2022
|
Charles Morgan Kendrick Jr EVP & President, Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
6,328
+7.66%
|
$1,771,840
$280.62 P/Share
|
|
Jun 06
2022
|
Robert L Dixon Jr Director |
SELL
Open market or private sale
|
Direct |
420
-4.24%
|
$208,740
$497.14 P/Share
|
|
May 19
2022
|
Ramiro G Peru Director |
SELL
Open market or private sale
|
Direct |
990
-9.52%
|
$463,320
$468.88 P/Share
|
|
May 18
2022
|
Robert L Dixon Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
440
+4.25%
|
-
|
|
May 18
2022
|
Bahija Jallal Director |
BUY
Grant, award, or other acquisition
|
Direct |
440
+11.63%
|
-
|
|
May 18
2022
|
Ryan M. Schneider Director |
BUY
Grant, award, or other acquisition
|
Direct |
440
+7.87%
|
-
|
|
May 18
2022
|
Elizabeth E Tallett Director |
BUY
Grant, award, or other acquisition
|
Direct |
440
+4.45%
|
-
|
|
May 18
2022
|
R Kerry Clark Director |
BUY
Grant, award, or other acquisition
|
Direct |
440
+5.1%
|
-
|
|
May 18
2022
|
Ramiro G Peru Director |
BUY
Grant, award, or other acquisition
|
Direct |
440
+4.06%
|
-
|
|
May 18
2022
|
Lewis Hay Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
440
+4.19%
|
-
|
|
May 18
2022
|
Susan D. De Vore Director |
BUY
Grant, award, or other acquisition
|
Direct |
440
+33.95%
|
-
|
|
May 18
2022
|
Antonio F Neri Director |
BUY
Grant, award, or other acquisition
|
Direct |
440
+11.23%
|
-
|